Tom Julian

Tom Julian is a seasoned professional in digital health and clinical trial innovation with extensive experience in transforming digital ecosystems and enhancing patient engagement. Currently serving as a Senior Consultant for Digital Health at Gilead Sciences since May 2022, Tom previously worked at Bristol Myers Squibb as Associate Director, focusing on clinical trial digital capabilities and leading the development of the award-winning BMS Study Connect platform. At EmblemHealth, Tom notably transformed the organization’s digital strategy from B2B to B2C in response to the Affordable Care Act. Earlier roles include positions at Empire Blue Cross Blue Shield, where Tom prioritized and managed web content, and ChannelSeven.com, where Tom coordinated digital production efforts. Tom holds a Bachelor's degree in Communications from Stockton University.